We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EL:BVBSocietatea Energetica Electrica S.A. Analysis

Data as of 2026-06-13 - not real-time

$89.68

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at $89.68, comfortably above its 20‑day ($84.56) and 50‑day ($80.41) simple moving averages but still below the 200‑day SMA ($93.27), indicating short‑term strength within a longer‑term neutral backdrop. Momentum indicators are supportive – the RSI sits at 60.7 and the MACD line is bullish relative to its signal – while technical support sits near $75.26 and resistance near $92.35, giving the price a modest upside cushion. However, the DCF‑derived fair value of $63.53 is far below the current price, suggesting the market is pricing in expectations that are not yet reflected in fundamentals. Fundamentally, the company posted a negative profit margin (-1.67%) and a trailing EPS of -$0.70, yet forward EPS is projected at $3.18, implying a turnaround that is already baked into the forward P/E of 28.1. The balance sheet is heavily leveraged with a debt‑to‑equity ratio of 233, and the dividend payout ratio exceeds 400%, raising doubts about dividend sustainability despite a 1.56% yield. Recent material news – a $210 million settlement and the abrupt collapse of a $40 billion merger talk with Puig – sparked an 11‑13% rally, creating a short‑term profit‑taking opportunity. Overall, the stock sits in a high‑beta (1.55) and high‑volatility (52% 30‑day) environment, reflecting both market enthusiasm and underlying risk.
Given the overvaluation relative to intrinsic estimates, the unsustainable dividend policy, and the substantial debt load, the longer‑run outlook remains cautious. While the forward earnings guidance and potential acquisition pipeline could unlock value, the current price already reflects much of that optimism. Investors should weigh the near‑term upside from recent catalysts against the medium‑ to long‑term risks of valuation pressure, leverage, and earnings volatility.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Recent 13% rally on merger talk collapse
  • High short‑term volatility and beta
  • Price near technical resistance

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Forward earnings upside expected
  • Potential acquisition opportunities
  • Elevated debt and dividend sustainability concerns

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Current price well above DCF fair value
  • Heavy leverage (debt‑to‑equity >200%)
  • Unsustainable dividend payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin-1.67%
P/E Ratio28.1
ROE-5.95%
ROA4.87%
Debt/Equity232.91
P/B Ratio8.1
Op. Cash Flow$1.8B
Free Cash Flow$1.8B

Technical Analysis

TrendNeutral
RSI60.7
Support$75.26
Resistance$92.35
MA 20$84.56
MA 50$80.41
MA 200$93.27
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value$63.53
Target Price$95.12
Upside/Downside6.07%
GradeOvervalued
TypeBlend
Dividend Yield1.56%

Risk Assessment

Beta1.55
Volatility52.40%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.